Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interaction between Platelia Aspergillus ELISA test and piperacillin/tazobactam
2004-001321-25Phase 4Completed
- Sponsor
- Wyeth
- Start
- Jul 2004
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of piperacillin + tazobactam in aspergillosis, sponsored by Wyeth. Started Jul 2004; status: completed.
02
Drugs
piperacillin + tazobactam
03
Conditions
aspergillosis
Beyond the preview
Go deeper on 2004-001321-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001321-25.